Dipharma awarded Bronze Medal by EcoVadis for Sustainability
Panel discussion on Custom synthesis & Contract manufacturing
Pharma Tech Outlook Europe awards Dipharma as “CDMO Solution of the Year in Europe 2025”
Panel discussion on Custom synthesis & Contract manufacturing
Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma granted first CADIFA by Brazilian ANVISA for the Ursodeoxycholic Acid
Panel discussion on Custom synthesis & Contract manufacturing
CANDESARTAN CILEXETIL
Therapeutic class: Antihypertensive CAS number: 145040-37-5 Regulatory status: EU [...]
Dipharma at the XXVIII National Congress of the Italian Chemical Society
Panel discussion on Custom synthesis & Contract manufacturing
Dipharma & Flow Chemistry: Lesson at University, CNR, and Industry Meeting
Another appointment related to Dipharma’s collaboration with the academic [...]
API Production: Technology Transfer and Troubleshooting Management
The lesson by Alessio Bove, our Pilot Plant Manager [...]
Dipharma Francis S.r.l., the Shareholders’ Meeting Appoints the New Board of Directors
Panel discussion on Custom synthesis & Contract manufacturing
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
Panel discussion on Custom synthesis & Contract manufacturing
